Intellipharmaceutics International Inc. (IPCI)

[fabius]

Samsa, your frustration is like mine.
What is puzzling me is that if the value we see in the company is really there, why we don't have some institutional seriously buying and possibly taking the company majority ?

We have just seen CNAT more than doubling and now close to 100mln cap, after the Novartis deal, while they still have to run PhaseII trials. And they just have 1 drug working on.
And there are numerous other example for 2016.

now, if you want to look at the positive side, this seems to be confirming that the market doesn't really understand the proper potential (value?) of biotechs; big players more than often pay more than double the mkt cap.

on the negative, I really don't understand why we don't have aggressive accumulation going on, while being almost profitable and having huge catalyst approaching. I don't get it.

Manipulators play their game, but given the currant mkt cap it would take very little effort for a big pharma to get in control of IPCI, not just to push the shorters out, but just because the technology is truly valueable and you want to get in before Others do.

Your sarcastic view that we could go below 2 if partnership is announced and not tremendously lucrative I believe it's not pure fantasy.

right now it really seems that the only believers in this company are here on this board.